Both in Biotechnology
Century Therapeutics vs Kyverna Therapeutics
Over the past year IPSC returned +191.4% and KYTX returned −18.9%; their daily moves had a correlation of 0.24.
IPSC +191.4% KYTX −18.9%Growth of $1, one year, split-adjusted
| Metric | IPSC | KYTX |
|---|---|---|
| Price | $1.67 | $5.16 |
| Market cap | $302.4M | $319.1M |
| Today | +9.87% | 0.00% |
| 1 month | +26.5% | −16.2% |
| 6 months | −28.6% | −45.5% |
| Year to date | +67.9% | −45.1% |
| 1 year | +178.3% | −25.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | 75.0% | 59.8% |
| Short % of float | 23.4% | 26.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).